Marc R. Theoret

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

Marc R. Theoret

May 28, 2025, 07:50 | Blog

FDA Oncology - Overall Survival and PARP Inhibitors in Advanced Ovarian Cancer

FDA Oncology posted on X: "FDA article outlines the decision-making process and rationale behind removal…

Aug 23, 2024, 06:30 | Drugs

Taha Al-Juhaishi: Treatment of AML in the community setting

Taha Al-Juhaishi, Associate Director of Hematopoietic Stem Cell Transplantation and Cell Therapy at OU Health…

Jul 30, 2024, 13:23 | Insight

Treatment of CML in pregnant patients and patients who are breastfeeding

FDA Oncology shared on X: An expert panel convened by FDA provides perspectives on drug…

Jul 24, 2024, 07:43 | Blog

Considerations to improve collection and analysis of overall survival data in oncology clinical trials - AACR

AACR (American Association for Cancer Research) shared a post on LinkedIn: ''A new perspective paper…

Jul 15, 2024, 13:21 | Blog

Talha Badar: CRh as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia

Talha Badar shared on X: "Complete remission with partial hematological recovery as a palliative endpoint for…

All: 5 Posts: 1 - 100

'

15 Posts Not to Miss from the 1st Day of ASCO 2025

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023